COLPAL Colgate Palmolive (India) Q4 FY26 results (Jan–Mar 2026) and concall
Colgate-Palmolive (India) Limited reported a strong Q4 FY26 with accelerated net sales growth of 9% and domestic growth of 9.2%, driven by premiumization and core brand strength. Gross and EBITDA margins remained robust, with Q4 NPAT at ₹353 crores. While the full year saw flat top-line growth, the company is optimistic about future growth, focusing on balanced volume and pricing, and addressing challenges like the GST IDS impact and high promotional intensity.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 9.0%, net profit down 0.6% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 +2% | 1,595 +9% |
| EBITDA | 454 | 498 | 453 | 465 | 442 −3% | 510 +2% |
| Net profit | 323 | 355 | 321 | 328 | 324 +0% | 353 −1% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





